Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Seven-membered cycloplatinated complexes as a new family of anticancer agents. X-ray characterization and preliminary biological studies.

Cortés R, Crespo M, Davin L, Martín R, Quirante J, Ruiz D, Messeguer R, Calvis C, Baldomà L, Badia J, Font-Bardía M, Calvet T, Cascante M.

Eur J Med Chem. 2012 Aug;54:557-66. doi: 10.1016/j.ejmech.2012.06.002. Epub 2012 Jun 12.

PMID:
22770537
[PubMed - indexed for MEDLINE]
2.

Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.

Quirante J, Ruiz D, Gonzalez A, López C, Cascante M, Cortés R, Messeguer R, Calvis C, Baldomà L, Pascual A, Guérardel Y, Pradines B, Font-Bardía M, Calvet T, Biot C.

J Inorg Biochem. 2011 Dec;105(12):1720-8. doi: 10.1016/j.jinorgbio.2011.09.021. Epub 2011 Sep 22.

PMID:
22104300
[PubMed - indexed for MEDLINE]
3.

Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.

Talancón D, López C, Font-Bardía M, Calvet T, Quirante J, Calvis C, Messeguer R, Cortés R, Cascante M, Baldomà L, Badia J.

J Inorg Biochem. 2013 Jan;118:1-12. doi: 10.1016/j.jinorgbio.2012.09.007. Epub 2012 Sep 13.

PMID:
23123334
[PubMed - indexed for MEDLINE]
4.

Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.

Scaffidi-Domianello YY, Legin AA, Jakupec MA, Roller A, Kukushkin VY, Galanski M, Keppler BK.

Inorg Chem. 2012 Jul 2;51(13):7153-63. doi: 10.1021/ic300148e. Epub 2012 Jun 12.

PMID:
22691006
[PubMed - indexed for MEDLINE]
5.

Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.

Sbovata SM, Bettio F, Mozzon M, Bertani R, Venzo A, Benetollo F, Michelin RA, Gandin V, Marzano C.

J Med Chem. 2007 Sep 20;50(19):4775-84. Epub 2007 Aug 22.

PMID:
17713897
[PubMed - indexed for MEDLINE]
6.

Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.

Nieto D, González-Vadillo AM, Bruña S, Pastor CJ, Ríos-Luci C, León LG, Padrón JM, Navarro-Ranninger C, Cuadrado I.

Dalton Trans. 2012 Jan 14;41(2):432-41. doi: 10.1039/c1dt11358e. Epub 2011 Oct 25.

PMID:
22025199
[PubMed - indexed for MEDLINE]
7.

Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.

Alvarez-Valdés A, Pérez JM, López-Solera I, Lannegrand R, Continente JM, Amo-Ochoa P, Camazón MJ, Solans X, Font-Bardía M, Navarro-Ranninger C.

J Med Chem. 2002 Apr 25;45(9):1835-44.

PMID:
11960495
[PubMed - indexed for MEDLINE]
8.

Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.

Ruiz J, Villa MD, Cutillas N, López G, de Haro C, Bautista D, Moreno V, Valencia L.

Inorg Chem. 2008 Jun 2;47(11):4490-505. doi: 10.1021/ic701873b. Epub 2008 Apr 30.

PMID:
18447329
[PubMed - indexed for MEDLINE]
9.

Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity.

Cutillas N, Martínez A, Yellol GS, Rodríguez V, Zamora A, Pedreño M, Donaire A, Janiak C, Ruiz J.

Inorg Chem. 2013 Dec 2;52(23):13529-35. doi: 10.1021/ic401973k. Epub 2013 Nov 14.

PMID:
24229419
[PubMed - indexed for MEDLINE]
10.

Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.

Sun Y, Liu F, Gou S, Cheng L, Fang L, Yin R.

Eur J Med Chem. 2012 Sep;55:297-306. doi: 10.1016/j.ejmech.2012.07.026. Epub 2012 Jul 24.

PMID:
22867527
[PubMed - indexed for MEDLINE]
11.

Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.

Wirth S, Rohbogner CJ, Cieslak M, Kazmierczak-Baranska J, Donevski S, Nawrot B, Lorenz IP.

J Biol Inorg Chem. 2010 Mar;15(3):429-40. doi: 10.1007/s00775-009-0615-4. Epub 2009 Dec 19.

PMID:
20091072
[PubMed - indexed for MEDLINE]
12.

Pt(II) complexes with (N,N') or (C,N,E)(-) (E=N,S) ligands: cytotoxic studies, effect on DNA tertiary structure and structure-activity relationships.

Albert J, Bosque R, Crespo M, Granell J, López C, Cortés R, Gonzalez A, Quirante J, Calvis C, Messeguer R, Baldomà L, Badia J, Cascante M.

Bioorg Med Chem. 2013 Jul 15;21(14):4210-7. doi: 10.1016/j.bmc.2013.05.005. Epub 2013 May 14.

PMID:
23735827
[PubMed - indexed for MEDLINE]
13.

Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.

Hoeschele JD, Showalter HD, Kraker AJ, Elliott WL, Roberts BJ, Kampf JW.

J Med Chem. 1994 Aug 19;37(17):2630-6.

PMID:
8064793
[PubMed - indexed for MEDLINE]
14.

The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines.

Rakić GM, Grgurić-Šipka S, Kaluđerović GN, Bette M, Filipović L, Aranđelović S, Radulović S, Tešić ZLj.

Eur J Med Chem. 2012 Sep;55:214-9. doi: 10.1016/j.ejmech.2012.07.019. Epub 2012 Jul 22.

PMID:
22858225
[PubMed - indexed for MEDLINE]
15.

Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.

Matesanz AI, Joie C, Souza P.

Dalton Trans. 2010 Aug 14;39(30):7059-65. doi: 10.1039/c003007d. Epub 2010 Jun 23.

PMID:
20571622
[PubMed - indexed for MEDLINE]
16.

Mechanistic insight into protonolysis and cis-trans isomerization of benzylplatinum(II) complexes assisted by weak ligand-to-metal interactions. A combined kinetic and DFT study.

Guido E, D'Amico G, Russo N, Sicilia E, Rizzato S, Albinati A, Romeo A, Plutino MR, Romeo R.

Inorg Chem. 2011 Mar 21;50(6):2224-39. doi: 10.1021/ic101879s. Epub 2011 Feb 22.

PMID:
21341750
[PubMed - indexed for MEDLINE]
17.

Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.

Starha P, Trávnícek Z, Popa I.

J Inorg Biochem. 2010 Jun;104(6):639-47. doi: 10.1016/j.jinorgbio.2010.02.005. Epub 2010 Mar 3.

PMID:
20304500
[PubMed - indexed for MEDLINE]
18.

Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.

Mihajlović LE, Savić A, Poljarević J, Vučković I, Mojić M, Bulatović M, Maksimović-Ivanić D, Mijatović S, Kaluđerović GN, Stošić-Grujičić S, Miljković Đ, Grgurić-Šipka S, Sabo TJ.

J Inorg Biochem. 2012 Apr;109:40-8. doi: 10.1016/j.jinorgbio.2012.01.012. Epub 2012 Jan 31.

PMID:
22369771
[PubMed - indexed for MEDLINE]
19.

Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].

Mazzega Sbovata S, Bettio F, Marzano C, Tassan A, Mozzon M, Bertani R, Benetollo F, Michelin RA.

J Inorg Biochem. 2008 Apr;102(4):882-91. doi: 10.1016/j.jinorgbio.2007.12.007. Epub 2007 Dec 23.

PMID:
18267343
[PubMed - indexed for MEDLINE]
20.

Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.

Chen XZ, Ye QS, Lou LG, Xie MJ, Liu WP, Yu Y, Hou SQ.

Arch Pharm (Weinheim). 2008 Feb;341(2):132-6. doi: 10.1002/ardp.200700155.

PMID:
18186542
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk